The coactivator Bridge-1 increases transcriptional activation by pancreas duodenum homeobox-1 (PDX-1)

Molecular and Cellular Endocrinology

Volumn 237, Issue 1-2, 2005, Pages 67-74

  Stanojevic, Violeta ^a   Yao, Kwok Ming ^c   Thomas, Melissa K ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Bridge 1; Coactivator; Insulin; PDX 1; Transcription

Indexed keywords

BRIDGED COMPOUND; BRIDGED PEPTIDE; GLUCOSE; GLUTATHIONE TRANSFERASE; HOMEODOMAIN PROTEIN; HYBRID PROTEIN; INSULIN; MUTANT PROTEIN; SOMATOSTATIN; TRANSCRIPTION FACTOR GAL4;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DUODENUM; GENE CONTROL; GENE TARGETING; GLUCOSE METABOLISM; HUMAN; MATURITY ONSET DIABETES MELLITUS; NONHUMAN; PANCREAS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; REPORTER GENE; TRANSCRIPTION INITIATION; YEAST;

ANIMALS; DNA-BINDING PROTEINS; HMGB PROTEINS; HOMEODOMAIN PROTEINS; HUMANS; PROMOTER REGIONS (GENETICS); PROTEIN INTERACTION MAPPING; RATS; SACCHAROMYCES CEREVISIAE; SOMATOSTATIN; TCF TRANSCRIPTION FACTORS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 19544394114     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2005.03.003     Document Type: Article

References (47)

1. U. Ahlgren, J. Jonsson, L. Jonsson, K. Simu, and H. Edlund Beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes Genes Develop. 12 1998 1763 1768
2. H. Asahara, S. Dutta, H.Y. Kao, R.M. Evans, and M. Montminy Pbx-Hox heterodimers recruit coactivator-corepressor complexes in an isoform-specific manner Mol. Cell. Biol. 19 1999 8219 8225
3. M. Brissova, M. Shiota, W.E. Nicholson, M. Gannon, S.M. Knobel, D.W. Piston, C.V. Wright, and A.C. Powers Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion J. Biol. Chem. 277 2002 11225 11232
4. B.N. Cockburn, G. Bermano, L.L. Boodram, S. Teelucksingh, T. Tsuchiya, D. Mahabir, A.B. Allan, R. Stein, K. Docherty, and G.I. Bell Insulin promoter factor-1 mutations and diabetes in Trinidad: identification of a novel diabetes-associated mutation (E224K) in an Indo-Trinidadian family J. Clin. Endocrinol. Metab. 89 2004 971 978
5. S. Dutta, S. Bonner-Weir, M. Montminy, and C. Wright Regulatory factor linked to late-onset diabetes? Nature 392 1998 560
6. S. Dutta, M. Gannon, B. Peers, C. Wright, S. Bonner-Weir, and M. Montminy PDX:PBX complexes are required for normal proliferation of pancreatic cells during development Proc. Natl. Acad. Sci. U.S.A. 98 2001 1065 1070
7. S.C. Elbein, and M.A. Karim Does the aspartic acid to asparagine substitution at position 76 in the pancreas duodenum homeobox gene (PDX1) cause late-onset type 2 diabetes? Diabetes Care 27 2004 1968 1973
8. M.S. German, J. Wang, R.B. Chadwick, and W.J. Rutter Synergistic activation of the insulin gene by a LIM-homeodomain protein and a basic helix-loop-helix protein: building a functional insulin minienhancer complex Genes Develop. 6 1992 2165 2176
9. E.A. Golemis, J. Gyuris, and R. Brent Interaction trap/two-hybrid system to identify interacting proteins, Unit 13.14 F.M. Ausubel R. Brent R.E. Kingston D.D. Moore J.G. Seidman J.A. Smith K. Struhl Current Protocols in Molecular Biology vol. 2 1994 Wiley New York 13.14.1 13.14.17
10. G. Goudet, S. Delhalle, F. Biemar, J.A. Martial, and B. Peers Functional and cooperative interactions between the homeodomain PDX1, Pbx, and Prep1 factors on the somatostatin promoter J. Biol. Chem. 274 1999 4067 4073
11. G. Guillemain, G. Da Silva Xavier, I. Rafiq, A. Leturque, and G.A. Rutter Importin beta1 mediates the glucose-stimulated nuclear import of pancreatic and duodenal homeobox-1 in pancreatic islet beta-cells (MIN6) Biochem. J. 378 2004 219 227
12. E.H. Hani, D.A. Stoffers, J.C. Chevre, E. Durand, V. Stanojevic, C. Dina, J.F. Habener, and P. Froguel Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus J. Clin. Invest. 104 1999 R41 R48
13. L. Hansen, S. Urioste, H.V. Petersen, J.N. Jensen, H. Eiberg, F. Barbetti, P. Serup, T. Hansen, and O. Pedersen Missense mutations in the human insulin promoter factor-1 gene and their relation to maturity-onset diabetes of the young and late-onset type 2 diabetes mellitus in caucasians J. Clin. Endocrinol. Metab. 85 2000 1323 1326
14. A.M. Holland, M.A. Hale, H. Kagami, R.E. Hammer, and R.J. MacDonald Experimental control of pancreatic development and maintenance Proc. Natl. Acad. Sci. U.S.A. 99 2002 12236 12241
15. J.D. Johnson, W. Zhang, A. Rudnick, W.J. Rutter, and M.S. German Transcriptional synergy between LIM-homeodomain proteins and basic helix-loop-helix proteins: the LIM2 domain determines specificity Mol. Cell. Biol. 17 1997 3488 3496
16. J.D. Johnson, N.T. Ahmed, D.S. Luciani, Z. Han, H. Tran, J. Fujita, S. Misler, H. Edlund, and K.S. Polonsky Increased islet apoptosis in Pdx1+/- mice J. Clin. Invest. 111 2003 1147 1160
17. J. Jonsson, L. Carlsson, T. Edlund, and H. Edlund Insulin-promoter-factor 1 is required for pancreas development in mice Nature 371 1994 606 609
18. J. Leonard, B. Peers, T. Johnson, K. Ferreri, S. Lee, and M.R. Montminy Characterization of somatostatin transactivating factor-1, a novel homeobox factor that stimulates somatostatin expression in pancreatic islet cells Mol. Endocrinol. 7 1993 1275 1283
19. A. Liu, B.M. Desai, and D.A. Stoffers Identification of PCIF1, a POZ domain protein that inhibits PDX-1 (MODY4) transcriptional activity Mol. Cell. Biol. 24 2004 4372 4383
20. M. Lu, C. Miller, and J.F. Habener Functional regions of the homeodomain protein IDX-1 required for transactivation of the rat somatostatin gene Endocrinology 137 1996 2959 2967
21. W. MacFarlane, M.L. Read, M. Gilligan, I. Bujalska, and K. Docherty Glucose modulates the binding activity of the β cell transcription factor IUF-1 in a phosphorylation-dependent manner Biochem. J. 303 1994 625 631
22. W.M. MacFarlane, S.B. Smith, R.F. James, A.D. Clifton, Y.N. Doza, P. Cohen, and K. Docherty The p38/reactivating kinase mitogen-activated protein kinase cascade mediates the activation of the transcription factor insulin upstream factor 1 and insulin gene transcription by high glucose in pancreatic beta-cells J. Biol. Chem. 272 1997 20936 20944
23. W.M. MacFarlane, T.M. Frayling, S. Ellard, J.C. Evans, L.I. Allen, M.P. Bulman, S. Ayres, M. Shepherd, P. Clark, A. Millward, A. Demaine, T. Wilkin, K. Docherty, and A.T. Hattersley Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes J. Clin. Invest. 104 1999 R33 R39
24. M.E. Massari, and C. Murre Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms Mol. Cell. Biol. 20 2000 429 440
25. D. Melloul, Y. Ben-Neriah, and E. Cerasi Glucose modulates the binding of an islet-specific factor to a conserved sequence within the rat I and the human insulin promoters Proc. Natl. Acad. Sci. U.S.A. 90 1993 3865 3869
26. C.P. Miller, R.E. McGehee, and J.F. Habener IDX-1: a new homeodomain transcription factor expressed in rat pancreatic islets and duodenum that transactivates the somatostatin gene EMBO J. 13 1994 1145 1156
27. A.L. Mosley, and S. Ozcan The pancreatic duodenal homeobox-1 protein (pdx-1) interacts with histone deacetylases Hdac-1 and Hdac-2 on low levels of glucose J. Biol. Chem. 279 2004 54241 54247
28. M.F. Offield, T.L. Jetton, P.A. Labosky, M. Ray, R.W. Stein, M.A. Magnuson, B.L.M. Hogan, and C.V.E. Wright PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum Development 122 1996 983 995
29. H. Ohlsson, K. Karlsson, and T. Edlund IPF1, a homeodomain-containing transactivator of the insulin gene EMBO J. 12 1993 4251 4259
30. K. Ohneda, R.G. Mirmira, J. Wang, J.D. Johnson, and M.S. German The homeodomain of PDX-1 mediates multiple protein-protein interactions in the formation of a transcriptional activation complex on the insulin promoter Mol. Cell. Biol. 20 2000 900 911
31. K.R. Owen, J.C. Evans, T.M. Frayling, A.T. Hattersly, M.I. McCarthy, M. Walker, and G.A. Hitman Role of the D76N polymorphism of insulin promoter factor-1 in predisposing to Type 2 diabetes Diabetologia 47 2004 957 958
32. B. Peers, J. Leonard, S. Sharma, G. Teitelman, and M.R. Montminy Insulin expression in pancreatic islet cells relies on cooperative interactions between the helix loop helix factor E47 and the homeobox factor STF-1 Mol. Endocrinol. 8 1994 1798 1806
33. H.V. Petersen, M. Peshavaria, A.A. Pedersen, J. Philippe, R. Stein, O.D. Madsen, and P. Serup Glucose stimulates the activation domain potential of the PDX-1 homeodomain transcription factor FEBS Lett. 431 1998 362 366
34. Y. Qiu, M. Guo, S. Huang, and R. Stein Insulin gene transcription is mediated by interactions between the p300 coactivator and PDX-1, BETA2, and E47 Mol. Cell. Biol. 22 2002 412 420
35. I. Rafiq, H.J. Kennedy, and G.A. Rutter Glucose-dependent translocation of insulin promoter factor-1 (IPF-1) between the nuclear periphery and the nucleoplasm of single MIN6 β cells J. Biol. Chem. 273 1998 23241 23247
36. V.M. Schwitzgebel, A. Mamin, T. Brun, B. Ritz-Laser, M. Zaiko, A. Maret, F.R. Jornayvaz, G.E. Theintz, O. Michielin, D. Melloul, and J. Philippe Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1 J. Clin. Endocrinol. Metab. 88 2003 4398 4406
37. E.B. Shushan, E. Cerasi, and D. Melloul Regulation of the insulin gene by glucose: stimulation of trans-activation potency of human PDX-1 N-terminal domain DNA Cell. Biol. 18 1999 471 479
38. V. Stanojevic, J.F. Habener, and M.K. Thomas Pancreas duodenum homeobox-1 transcriptional activation requires interactions with p300 Endocrinology 145 2004 2918 2928
39. D.A. Stoffers, V. Stanojevic, and J.F. Habener Insulin promoter factor-1 gene mutation linked to early-onset type 2 diabetes mellitus directs expression of a dominant negative isoprotein J. Clin. Invest. 102 1998 232 241
40. D.A. Stoffers, J. Ferrer, W.L. Clarke, and J.F. Habener Early-onset type-II diabetes mellitus (MODY4) linked to IPF-1 Nat. Genet. 17 1997 138 139
41. D.A. Stoffers, N.T. Zinkin, V. Stanojevic, W.L. Clarke, and J.F. Habener Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 coding region Nat. Genet. 15 1997 106 110
42. M.K. Thomas, and J.F. Habener IDX-1: pancreatic agenesis and type 2 diabetes P. Erikson C.J. Epstein A. Wynshaw-Boris Molecular Basis of Inborn Errors of Development 2004 Oxford University Press Oxford 552 556
43. M.K. Thomas, K.M. Yao, M.S. Tenser, G.G. Wong, and J.F. Habener Bridge-1, a novel PDZ-domain coactivator of E2A-mediated regulation of insulin gene transcription Mol. Cell. Biol. 19 1999 8492 8504
44. M.K. Thomas, O.N. Devon, J.H. Lee, A. Peter, D.A. Schlosser, M.S. Tenser, and J.F. Habener Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1 J. Clin. Invest. 108 2001 319 329
45. G. Waeber, J. Delplanque, C. Bonny, V. Mooser, M. Steinmann, C. Widmann, A. Maillard, J. Miklossy, C. Dina, E.H. Hani, N. Vionnet, P. Nicod, P. Boutin, and P. Froguel The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes Nat. Genet. 24 2000 291 295
46. J. Weng, W.M. MacFarlane, M. Lehto, H.F. Gu, L.M. Shepherd, S.A. Ivarsson, L. Wibell, T. Smith, and L.C. Groop Functional consequences of mutations in the MODY4 gene (IPF1) and coexistence with MODY3 mutations Diabetologia 44 2001 249 258
47. J. Weng, M. Ekelund, M. Lehto, H. Li, G. Ekberg, A. Frid, A. Aberg, L.C. Groop, and K. Berntorp Screening for MODY mutations, GAD antibodies, and type 1 diabetes-associated HLA genotypes in women with gestational diabetes mellitus Diabetes Care 25 2002 68 71